Grimaldi's shareholders' meeting agrees on a capital increase of EUR 50 million in Trasmed to strengthen its balance sheet

The Grimaldi Group has decided to carry out a new capital increase in its Spanish subsidiary Trasmed, worth EUR 50 million. The decision aims to strengthen the company's financial position and reduce its debt load. With this transaction, Trasmed's share capital will reach EUR 347 million.

The company, which operates ferry services between the Peninsula and the Balearic Islands, was incorporated in 2021 after the purchase of assets from the Armas Trasmediterránea group. This capital injection by the parent company will be specifically used to reduce accumulated debt, mainly derived from the syndicated loan signed to finance the initial acquisition of the vessels that make up its asset. Once the increase is executed, Trasmed's total debt will be reduced to EUR 26.4 million.

The Grimaldi Group has closed 2024 with more than EUR 1,400 million in cash and a turnover of more than EUR 5,000 million.

Jul 03 2025